Livelsberger Financial Advisory purchased a new stake in Elevance Health, Inc. (NYSE:ELV – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 297 shares of the company’s stock, valued at approximately $155,000. Elevance Health accounts for about 3.2% of Livelsberger Financial Advisory’s holdings, making the stock its 8th largest holding.
Several other hedge funds have also recently bought and sold shares of the business. Capital Advisors Ltd. LLC raised its stake in shares of Elevance Health by 8.8% during the first quarter. Capital Advisors Ltd. LLC now owns 248 shares of the company’s stock valued at $129,000 after purchasing an additional 20 shares in the last quarter. Bedel Financial Consulting Inc. raised its stake in shares of Elevance Health by 1.6% during the first quarter. Bedel Financial Consulting Inc. now owns 1,247 shares of the company’s stock valued at $647,000 after purchasing an additional 20 shares in the last quarter. American Trust raised its position in Elevance Health by 2.6% in the first quarter. American Trust now owns 775 shares of the company’s stock worth $402,000 after acquiring an additional 20 shares in the last quarter. Fiduciary Alliance LLC raised its position in Elevance Health by 3.6% in the first quarter. Fiduciary Alliance LLC now owns 611 shares of the company’s stock worth $315,000 after acquiring an additional 21 shares in the last quarter. Finally, Ascent Wealth Partners LLC raised its position in Elevance Health by 1.8% in the first quarter. Ascent Wealth Partners LLC now owns 1,193 shares of the company’s stock worth $619,000 after acquiring an additional 21 shares in the last quarter. Hedge funds and other institutional investors own 89.24% of the company’s stock.
Insider Activity at Elevance Health
In related news, EVP Charles Morgan Kendrick, Jr. sold 7,417 shares of the business’s stock in a transaction that occurred on Friday, October 18th. The stock was sold at an average price of $432.14, for a total value of $3,205,182.38. Following the completion of the sale, the executive vice president now owns 8,423 shares of the company’s stock, valued at approximately $3,639,915.22. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other Elevance Health news, Director Ramiro G. Peru sold 753 shares of the company’s stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $531.52, for a total transaction of $400,234.56. Following the completion of the sale, the director now owns 8,744 shares of the company’s stock, valued at $4,647,610.88. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Charles Morgan Kendrick, Jr. sold 7,417 shares of the company’s stock in a transaction that occurred on Friday, October 18th. The stock was sold at an average price of $432.14, for a total value of $3,205,182.38. Following the sale, the executive vice president now directly owns 8,423 shares of the company’s stock, valued at $3,639,915.22. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
Check Out Our Latest Report on Elevance Health
Elevance Health Stock Down 1.4 %
NYSE:ELV traded down $6.04 on Monday, hitting $424.73. 997,900 shares of the company’s stock traded hands, compared to its average volume of 1,078,164. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.58. Elevance Health, Inc. has a 1 year low of $397.98 and a 1 year high of $567.26. The firm has a 50-day moving average price of $526.74 and a 200-day moving average price of $527.81. The company has a market cap of $98.71 billion, a PE ratio of 16.25, a price-to-earnings-growth ratio of 1.08 and a beta of 0.82.
Elevance Health (NYSE:ELV – Get Free Report) last released its earnings results on Thursday, October 17th. The company reported $8.37 earnings per share for the quarter, missing the consensus estimate of $9.66 by ($1.29). The business had revenue of $44.72 billion for the quarter, compared to analysts’ expectations of $43.47 billion. Elevance Health had a net margin of 3.89% and a return on equity of 20.64%. The company’s revenue was up 5.3% compared to the same quarter last year. During the same period last year, the firm earned $8.99 EPS. Equities analysts anticipate that Elevance Health, Inc. will post 37.26 EPS for the current fiscal year.
Elevance Health Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Thursday, December 5th will be paid a $1.63 dividend. The ex-dividend date is Thursday, December 5th. This represents a $6.52 annualized dividend and a dividend yield of 1.54%. Elevance Health’s payout ratio is 24.64%.
About Elevance Health
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Recommended Stories
- Five stocks we like better than Elevance Health
- What Investors Need to Know to Beat the Market
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- Dividend Payout Ratio Calculator
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV – Free Report).
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.